Questions before the New Year…

A panelist discusses how diagnosing posttraumatic stress disorder (PTSD) presents unique challenges due to symptom overlap with other mental health conditions, varying presentation across different populations, and the often-delayed onset of symptoms following traumatic events.

A panelist discusses how posttraumatic stress disorder (PTSD) manifests through a complex web of symptoms, including intrusive memories, nightmares, hypervigilance, emotional numbness, and avoidance behaviors that significantly impact daily functioning and quality of life.

An expert shares more about the recent data on NeuroStar advanced TMS. Learn more here.

A recent longitudinal, retrospective study aimed to examine antipsychotic prescribing and rehospitalization rates in a forensic psychiatric sample.

Remembering child psychiatrists…

New positive topline results from an open-label phase 2a study of IV psilocin benzoate in patients with major depressive disorder showed that the treatment delivers rapid, lasting antidepressant effects for up to 3 months following a single dose.

Researchers investigated the link between psychosis, criminal sanctions, and mortality rates following discharge from a hospital for acute psychosis.

Would you like to be featured in an upcoming print issue? Submit an article on child & adolescent psychiatry!

MindMed announced phase 3 study of psychedelic MM120 for Generalized Anxiety Disorder.

Extreme risk protection orders may be an effective suicide prevention tool.

What are the psychological challenges of this upcoming holiday season?

MindMed announced phase 3 of a trial testing a new treatment for generalized anxiety disorder is under way.

Top stories from the weekend highlighted heroes and villains and underlined the need to address mental health.

In some cases of child murder by the mother, psychiatrists may have a critical role in prevention. Learn more here.

A panelist discusses how posttraumatic stress disorder (PTSD) alters key brain regions, such as the amygdala and hippocampus, with genetic predisposition, severity of trauma exposure, and lack of social support serving as critical risk factors that can influence both the likelihood of developing the condition and its neurobiological impact.

A panelist discusses how posttraumatic stress disorder (PTSD) permeates modern society at multiple levels, from individuals coping with personal trauma to collective trauma responses that shape community behaviors and social structures.

Catch up on coverage from the 63rd Annual Meeting of the American College of Neuropsychopharmacology in Phoenix, Arizona.

Patients with personality disorders would benefit from therapy regardless of modality, duration, or intensity.

"Here the body’s art conspires with destruction..."

What if biomarkers could tell you whether or not a depression treatment would work before a patient started?

How can Ibogaine help patients with Alcohol Use Disorder, specifically in veterans?

What effects do lifestyle factors have on brain aging and neuropsychiatic symptoms?